Strata Skin Sciences, Inc.
SSKN
$1.43
-$0.05-3.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.23% | -9.15% | 0.86% | 10.21% | -0.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.23% | -9.15% | 0.86% | 10.21% | -0.62% |
| Cost of Revenue | -21.82% | -2.92% | -13.85% | -1.77% | -9.93% |
| Gross Profit | -20.85% | -13.48% | 18.41% | 19.91% | 6.70% |
| SG&A Expenses | -11.72% | 22.42% | -2.83% | 6.19% | 24.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.54% | 10.83% | -8.46% | 0.98% | 9.88% |
| Operating Income | -15.70% | -357.61% | 30.25% | 68.37% | -160.98% |
| Income Before Tax | 21.79% | -2,414.14% | 27.79% | -20.10% | -96.96% |
| Income Tax Expenses | -- | -- | -- | -84.78% | -- |
| Earnings from Continuing Operations | 21.79% | -2,414.14% | 27.79% | -18.53% | -96.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.79% | -2,414.14% | 27.79% | -18.53% | -96.96% |
| EBIT | -15.70% | -357.61% | 30.25% | 68.37% | -160.98% |
| EBITDA | -171.31% | -231.68% | 51.52% | 608.20% | -143.88% |
| EPS Basic | 29.52% | -2,015.96% | 39.30% | 0.54% | -70.26% |
| Normalized Basic EPS | -0.22% | -117.18% | 39.31% | 57.78% | -70.24% |
| EPS Diluted | 29.52% | -2,015.96% | 39.30% | 0.54% | -70.26% |
| Normalized Diluted EPS | -0.22% | -117.18% | 39.31% | 57.78% | -70.24% |
| Average Basic Shares Outstanding | 10.95% | 18.97% | 18.97% | 19.17% | 15.69% |
| Average Diluted Shares Outstanding | 10.95% | 18.97% | 18.97% | 19.17% | 15.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |